Online supplementary table S7. List of quality indicators for RUM Donabe c- c- c- dian's QI ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC-ATC ATC ATC ATC ATC ATC ATC ATC No. Reference Year Country Denominator Numerator Definition DRP- DRP- DRP- framew typeb 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1 2 3 orka # of essential emergency medication available within the EU 1 Broccoli et al. 1 2018 Africa # of essential emergency medications listed % of essential medications available in the EU S Ge 6 N/A N/A at time of assessment 2 Broccoli et al. 1 2018 Africa # of EUs within the region # of EUs with clinical guidelines for emergency care % of EUs with clinical guidelines for emergency care S Ge 9 N/A N/A 3 Broccoli et al. 1 2018 Africa # of EUs within the region # of EUs with sepsis protocol % of EUs with sepsis protocol S Me 9 J01 J 4 Broccoli et al. 1 2018 Africa # of EUs within the region # of EUs with reactive airway disease protocol % of EUs with reactive airway disease protocol S Me 9 R03 R # of EUs with regular audits of EU diagnostics and/or % of EUs with regular audits of EU diagnostics and/or 5 Broccoli et al. 1 2018 Africa # of EUs within the region S Ge 9 N/A N/A treatment compliance as dictated by local priority treatment compliance as dictated by local priority # of patients < 5 with pneumonia given antibiotics during EU % of patients < 5 with pneumonia given antibiotics during EU 6 Broccoli et al. 1 2018 Africa # of patients < 5 with pneumonia P Me 1 J01 J length of stay length of stay # of patients with documentation of asthma who receive % of patients with documentation of asthma who receive 7 Broccoli et al. 1 2018 Africa # of patients with documentation of asthma P Me 1 R03 R bronchodilator treatment bronchodilator treatment # of adult patients with pneumonia given antibiotics during EU % of adult patients with pneumonia given antibiotics during EU 8 Broccoli et al. 1 2018 Africa # of adult patients with pneumonia P Me 1 J01 J length of stay length of stay 9 Broccoli et al. 1 2018 Africa # of adult patients with SBP < 90 mmHg # of adult patients with SBP < 90 mmHg given IV fluids % of adult patients with SBP < 90 given IV fluids P Me 1 B05 B # of patients with postpartum haemorrhage who receive % of patients with postpartum haemorrhage who receive 10 Broccoli et al. 1 2018 Africa # of patients with postpartum haemorrhage P Me 1 B05 B medication to control bleeding medication to control bleeding 11 Broccoli et al. 1 2018 Africa # of patients with blood glucose < 70 mg/dL # of patients with blood glucose < 70 mg/dL given glucose % of patients with blood glucose < 70 mg/dL given glucose P Me 1 B05 B # of patients with oxygen saturation < 92% with % of patients with oxygen saturation < 92% who had 12 Broccoli et al. 1 2018 Africa # of patients with oxygen saturation < 92 % P Me 1 V03 V documentation of supplemental O2 supplemental oxygen given # of patients with diagnosis of eclampsia or pre-eclampsia % of patients with diagnosis of eclampsia or pre-eclampsia 13 Broccoli et al. 1 2018 Africa # of patients with diagnosis of eclampsia or pre-eclampsia P Me 1 B05 B receiving magnesium receiving magnesium # of patients with active external bleeding who have physical % of patients with active external bleeding who have physical 14 Broccoli et al. 1 2018 Africa # of patients with active external bleeding P Me 1 B05 B manoeuvres applied to control haemorrhage documented manoeuvres applied to control haemorrhage # of patients meeting local transfusion criteria who receive % of patients meeting local transfusion criteria who receive 15 Broccoli et al. 1 2018 Africa # of patients meeting local transfusion criteria P Me 1 B05 B blood transfusion blood transfusion # of patients with a diagnosis of sepsis given antibiotics during % of patients with diagnosis of sepsis given antibiotics during 16 Broccoli et al. 1 2018 Africa # of patients with sepsis P Me 1 J01 J EU length of stay EU length of stay # of patients with documentation of asthma who receive % of patients with documentation of asthma who receive 17 Broccoli et al. 1 2018 Africa # of patients with documentation of asthma P Me 1 R03 R corticosteroid treatment corticosteroid treatment # of patients with documentation of pain who receive pain % of patients with documentation of pain who receive pain 18 Broccoli et al. 1 2018 Africa # of patients with documentation of pain PMe1 M01 M02 N02 MN medications medications # of patients age > 18 with open wound and documentation of % of patients age > 18 with open wound and documentation 19 Broccoli et al. 1 2018 Africa # of patients age > 18 with open wound tetanus vaccination given (or patient’s reported recent of tetanus vaccination given (or patient’s reported recent P Me 1 J07 J vaccination) vaccination) Number of patients 65 years of age and older who fall during Number of patients 65 years of age and older who fall during hospitalisation in whom presence or absence of prodromal 20 Tropea et al. 2 2011 Australia P Ge 7 N/A N/A hospitalisation symptoms and review of medications or drugs potentially contributing to the fall is documented Number of patients aged 65 years and older whose current 21 Tropea et al. 2 2011 Australia Number of patients aged 65 years and older in sample P Ge 6 N/A N/A medications are documented and reconciled at admission Number of discharge summaries, of patients aged 65 years Number of discharge summaries in sample of patients aged 22 Tropea et al. 2 2011 Australia and older, that include medication therapy changes and P Ge 6 N/A N/A 65 years and older explanations for changes Number of patients aged 65 years and older receiving Number of patients aged 65 years and older receiving 23 Tropea et al. 2 2011 Australia PMe1 N05 N sedatives at discharge sedatives at discharge that were not taking them at admission Number of regular clients during the reference period who The percentage of regular clients whose medicines have been 24 2012 Australia Number of regular clients during the reference period. have had their medicines reviewed according to locally agreed reviewed by a healthcare practitioner in accordance with P Ge 7 N/A N/A ACSQHC3 timeframes. locally agreed guidelines. Number of clients in the population or sample whose The percentage of clients whose medication list has been 25 2012 Australia All clients in the population or sample. medication list has been reconciled against the service’s P Ge 6 N/A N/A reconciled against the service’s patient health record. ACSQHC3 patient health record. Number of patient records in the sample where known The percentage of clients whose known adverse drug 26 2012 Australia Number of patient records in the sample. adverse drug reactions and medication allergies are reactions and medication allergies are documented in the P Ge 7 N/A N/A ACSQHC3 documented. service’s patient health record. Number of adult patients receiving VTE prophylaxis Percentage of hospitalised adult patients that receive venous 27 2014 Australia Number of adult patients in sample PMe1 B01 B appropriate to their level of risk thromboembolism prophylaxis appropriate to their level of risk ACSQHC4, Number of patients prescribed enoxaparin whose dosing Percentage of patients prescribed enoxaparin whose dosing 28 4, 2014 Australia Number of patients prescribed enoxaparin in sample PMe3 B01 B ACSQHC schedule is appropriate schedule is appropriate Percentage of patients prescribed hospital initiated warfarin Number of patients on hospital initiated warfarin whose 29 2014 Australia Number of patients on hospital initiated warfarin in sample whose loading doses are consistent with a drug and PMe3 B01 B loading doses are consistent with a DTC approved protocol ACSQHC4, therapeutics committee approved protocol Number of patients with INR above 4 whose dosage has been Percentage of patients with an INR above 4 whose dosage 30 2014 Australia Number of patients with INR above 4 in sample PMe7 B01 B adjusted or reviewed prior to the next warfarin dose has been adjusted or reviewed prior to the next warfarin dose ACSQHC4, Number of patients with AF that are discharged on an oral Percentage of patients with atrial fibrillation that are 31 4, 2014 Australia Number of patients discharged with AF in sample PMe1 B01 B ACSQHC anticoagulant discharged on oral anticoagulants Percentage of patients undergoing specified surgical Number of patients who had a specified surgical procedure in Number of patients undergoing specified surgical procedures 32 2014 Australia procedures that receive an appropriate prophylactic antibiotic PMe1 J01 J sample that receive an appropriate prophylactic antibiotic regimen ACSQHC4, regimen Percentage of prescriptions for restricted antibiotics that are Number of prescriptions for restricted antibiotics that are 33 2014 Australia Number of prescriptions for restricted antibiotics in sample concordant with drug and therapeutics committee approved PMe1 J01 J concordant with DTC approved criteria ACSQHC4, criteria Number of patients who received aminoglycoside therapy Number of patients who received doses of empirical Percentage of patients in whom doses of empirical 34 4, 2014 Australia PMe1 J01 J ACSQHC beyond 48 hours in sample aminoglycoside therapy beyond 48 hours aminoglycoside therapy are continued beyond 48 hours Percentage of patients presenting with community acquired Number of patients presenting with CAP that are prescribed 35 2014 Australia Number of patients presenting with CAP in sample